Abstract
From Washington, D.C., NewsRx journali sts report that a patent application by the inventors Earls, James P. (Fairfax S tation, VA, US); Min, James K. (Denver, CO, US); Rodrigues Marques, Hugo Miguel (Lisbon, PT), filed on April 19, 2024, was made available online on September 19 , 2024. The patent's assignee is Cleerly Inc. (Denver, Colorado, United States). News editors obtained the following quote from the background information suppli ed by the inventors: "Coronary heart disease affects over 17.6 million Americans . The current trend in treating cardiovascular health issues is generally two-fo ld. First, physicians generally review a patient's cardiovascular health from a macro level, for example, by analyzing the biochemistry or blood content or biom arkers of a patient to determine whether there are high levels of cholesterol el ements in the bloodstream of a patient. In response to high levels of cholestero l, some physicians will prescribe one or more drugs, such as statins, as part of a treatment plan in order to decrease what is perceived as high levels of chole sterol elements in the bloodstream of the patient.
NETL
NSTL